PTH vs. BIB
PTH (Invesco DWA Healthcare Momentum ETF) and BIB (ProShares Ultra Nasdaq Biotechnology) are both exchange-traded funds - PTH is a Momentum fund tracking the Dorsey Wright Healthcare Technical Leaders Index, while BIB is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (200%). Both are passively managed. Over the past 10 years, PTH returned 12.78%/yr vs 5.68%/yr for BIB. Their correlation of 0.81 suggests significant overlap in exposure. PTH charges 0.60%/yr vs 0.95%/yr for BIB.
Performance
PTH vs. BIB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PTH achieves a -1.13% return, which is significantly lower than BIB's -0.51% return. Over the past 10 years, PTH has outperformed BIB with an annualized return of 12.78%, while BIB has yielded a comparatively lower 5.68% annualized return.
PTH
- 1D
- 1.64%
- 1M
- -4.72%
- YTD
- -1.13%
- 6M
- -4.72%
- 1Y
- 34.27%
- 3Y*
- 8.31%
- 5Y*
- -0.77%
- 10Y*
- 12.78%
BIB
- 1D
- 3.49%
- 1M
- -3.84%
- YTD
- -0.51%
- 6M
- -3.00%
- 1Y
- 76.61%
- 3Y*
- 14.49%
- 5Y*
- -1.02%
- 10Y*
- 5.68%
PTH vs. BIB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PTH Invesco DWA Healthcare Momentum ETF | -1.13% | 27.91% | 2.36% | -4.54% | -20.61% | -3.20% | 67.26% | 34.45% | -1.23% | 50.15% |
BIB ProShares Ultra Nasdaq Biotechnology | -0.51% | 59.21% | -9.84% | -1.06% | -28.85% | -6.02% | 39.79% | 46.71% | -24.93% | 40.49% |
Correlation
The correlation between PTH and BIB is 0.80, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.80 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.79 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.81 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.81 |
Correlation (All Time) Calculated using the full available price history since Apr 9, 2010 | 0.81 |
The correlation between PTH and BIB has been stable across timeframes, ranging from 0.79 to 0.81 - a consistent structural relationship.
PTH vs. BIB - Sectors Allocation Comparison
Sectors
PTH
BIB
Healthcare
Financial Services
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
PTH
BIB
Financial Services
PTH
BIB
Basic Materials
PTH
-
BIB
-
Communication Services
PTH
-
BIB
-
Consumer Cyclical
PTH
-
BIB
-
Consumer Defensive
PTH
-
BIB
-
Energy
PTH
-
BIB
-
Industrials
PTH
-
BIB
-
Real Estate
PTH
-
BIB
-
Technology
PTH
-
BIB
-
Utilities
PTH
-
BIB
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PTH vs. BIB — Risk / Return Rank
PTH
BIB
PTH vs. BIB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco DWA Healthcare Momentum ETF (PTH) and ProShares Ultra Nasdaq Biotechnology (BIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PTH | BIB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.47 | ||
| Sortino ratioReturn per unit of downside risk | -0.40 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.30 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 2.87 | 4.55 | -1.68 |
| Martin ratioReturn relative to average drawdown | 7.37 | 14.49 | -7.12 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PTH | BIB | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.48 | 1.95 | -0.47 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.03 | -0.02 | -0.01 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.47 | 0.12 | +0.35 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.40 | 0.34 | +0.06 |
Drawdowns
PTH vs. BIB - Drawdown Comparison
The maximum PTH drawdown since its inception was -53.52%, smaller than the maximum BIB drawdown of -67.24%. Use the drawdown chart below to compare losses from any high point for PTH and BIB.
Loading charts...
Drawdown Indicators
| PTH | BIB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -53.52% | -67.24% | +13.72% |
Max Drawdown (1Y)Largest decline over 1 year | -11.98% | -16.92% | +4.94% |
Max Drawdown (3Y)Largest decline over 3 years | -28.70% | -45.30% | +16.60% |
Max Drawdown (5Y)Largest decline over 5 years | -50.07% | -65.86% | +15.79% |
Max Drawdown (10Y)Largest decline over 10 years | -53.52% | -66.20% | +12.68% |
Current DrawdownCurrent decline from peak | -19.32% | -26.85% | +7.53% |
Average DrawdownAverage peak-to-trough decline | -17.00% | -32.74% | +15.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.66% | 5.30% | -0.64% |
Volatility
PTH vs. BIB - Volatility Comparison
The current volatility for Invesco DWA Healthcare Momentum ETF (PTH) is 8.84%, while ProShares Ultra Nasdaq Biotechnology (BIB) has a volatility of 13.91%. This indicates that PTH experiences smaller price fluctuations and is considered to be less risky than BIB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PTH | BIB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.84% | 13.91% | -5.07% |
Volatility (6M)Calculated over the trailing 6-month period | 17.83% | 30.57% | -12.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.31% | 39.59% | -16.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.49% | 43.56% | -18.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.24% | 46.50% | -19.26% |
PTH vs. BIB - Expense Ratio Comparison
PTH has a 0.60% expense ratio, which is lower than BIB's 0.95% expense ratio.
Dividends
PTH vs. BIB - Dividend Comparison
PTH's dividend yield for the trailing twelve months is around 3.11%, more than BIB's 0.62% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 0.62% | 0.77% | 1.69% | 0.07% | 0.03% |
PTH Invesco DWA Healthcare Momentum ETF | 3.11% | 3.07% | 0.06% | 0.00% | 0.00% |
Frequently Asked Questions
PTH and BIB have a correlation of 0.80, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIB has higher volatility (13.91%) compared to PTH (8.84%). In terms of maximum drawdown, PTH dropped -53.52% vs BIB's -67.24%.
On 10-year performance, PTH leads with 12.78% vs 5.68% for BIB. On fees, PTH is cheaper at 0.60% per year. On volatility, PTH has been the lower-risk option at 8.84%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, PTH has performed better with a 12.78% return vs 5.68%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PTH is cheaper with a 0.60% expense ratio, compared with 0.95% for BIB.
PTH has the higher dividend yield at 3.11%, compared with 0.62% for BIB.
PTH is categorized as Momentum, while BIB is Leveraged Equities. PTH tracks Dorsey Wright Healthcare Technical Leaders Index, while BIB tracks NASDAQ Biotechnology Index (200%). They also come from different issuers: Invesco and ProShares. Their fees differ too: 0.60% for PTH and 0.95% for BIB.
BIB currently has the higher Sharpe Ratio (1.95 vs 1.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PTH and BIB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer